Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced Hepatocellular Carcinoma
NCT00946153Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lenvatinib in hepatocellular carcinoma (HCC), sponsored by Eisai Co., Ltd.. Started Jul 2009; status: completed.
02
Drugs
lenvatinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00946153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946153.